Answers are grounded in this paper and cite their sources.
An evaluation of the 30-day safety and performance outcomes of the Phoenix atherectomy system (Philips Volcano Corporation) was performed in real-world patients with peripheral artery disease (PAD).
No takes yet. Share an insight, caveat, or question.
Shishehbor et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: